Phil King’s Regal writes Opthea to zero and backs off risky bets
The veteran stockpicker told investors the firm would review how its $220 million wager on the biotech went so wrong “to ...
Opthea Limited (CKDXF) was downgraded to a Sell Rating at Bell Potter
Opthea Limited (CKDXF – Research Report) received a Sell rating and a A$0.05 price target from Bell Potter analyst Thomas Wakim yesterday. The ...
BioPharma Dive9h
Leqembi’s EU review drags on; Sanofi gets a new development head
The European Commission has referred Eisai and Biogen’s application to an appeals committee. Elsewhere, Opthea warned of ...
HotCopper on MSN20hOpinion
Listen: HotCopper Podcast 008 – Take-off time... or is it more taxiing?
Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon ...
FNArena3h
The Overnight Report: Trump Kills Rally In The Rose Garden
At a blustery Rose Garden event, Trump unveiled a 10% across-the-board tariff on all imports, alongside targeted tariffs of ...
Market Index on MSN18h
Evening Wrap: ASX 200 rally stalls as mining and energy shares dumped ahead of Trump Liberation Day speech
The S&P/ASX 200 closed 9.3 points higher, up 0.12%. On surface, a quiet day for Aussie stocks. But this could not be further from the case! There were equally big winners and losers across the major ...
Explore more